Extended-release injectable naltrexone combined with extended-release oral bupropion (NTX + BUPN) for moderate or severe methamphetamine use disorder was associated with a significant decrease in use ...
A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment. Participants in the ADAPT-2 clinical ...
Millions of people use methamphetamine in the United States, and overdoses involving the drug have been rising over the last decade. But while we have a veritable armory of tools to help with other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results